Atara Biotherapeutics Management
Management criteria checks 2/4
Atara Biotherapeutics' CEO is Pascal Touchon, appointed in Jun 2019, has a tenure of 4.83 years. total yearly compensation is $5.16M, comprised of 13.9% salary and 86.1% bonuses, including company stock and options. directly owns 0.25% of the company’s shares, worth $211.69K. The average tenure of the management team and the board of directors is 3.3 years and 8.4 years respectively.
Key information
Pascal Touchon
Chief executive officer
US$5.2m
Total compensation
CEO salary percentage | 13.9% |
CEO tenure | 4.8yrs |
CEO ownership | 0.2% |
Management average tenure | 3.3yrs |
Board average tenure | 8.4yrs |
Recent management updates
Recent updates
Atara Biotherapeutics: Opportunity As They Sell Off Their Approved Asset For Longer Runway
Feb 06Here's Why Atara Biotherapeutics (NASDAQ:ATRA) Must Use Its Cash Wisely
Oct 17Earnings Working Against Atara Biotherapeutics, Inc.'s (NASDAQ:ATRA) Share Price Following 32% Dive
May 18Need To Know: Analysts Are Much More Bullish On Atara Biotherapeutics, Inc. (NASDAQ:ATRA)
Feb 13Analysts Have Just Cut Their Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Revenue Estimates By 16%
Nov 22EMA panel backs approval of Atara's Ebvallo for transplant complication
Oct 14Atara Bio to get additional $30M milestone payment under collaboration with Pierre Fabre
Sep 28Atara: 2 Possible Regulatory Approvals For Tab-Cel, Plus CAR T Pipeline
Aug 17Atara adds 16% ahead of Phase 2 data for multiple sclerosis candidate
Jul 12Atara Biotherapeutics, Inc.'s (NASDAQ:ATRA) Intrinsic Value Is Potentially 42% Above Its Share Price
Jul 03Time To Worry? Analysts Just Downgraded Their Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Outlook
May 11Analysts Are Updating Their Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Estimates After Its Annual Results
Mar 02Atara Biotherapeutics: Early Stage Promises, Late Stage Delays
Feb 27CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | n/a | n/a | -US$276m |
Sep 30 2023 | n/a | n/a | -US$286m |
Jun 30 2023 | n/a | n/a | -US$305m |
Mar 31 2023 | n/a | n/a | -US$215m |
Dec 31 2022 | US$5m | US$718k | -US$228m |
Sep 30 2022 | n/a | n/a | -US$247m |
Jun 30 2022 | n/a | n/a | -US$248m |
Mar 31 2022 | n/a | n/a | -US$350m |
Dec 31 2021 | US$5m | US$681k | -US$340m |
Sep 30 2021 | n/a | n/a | -US$328m |
Jun 30 2021 | n/a | n/a | -US$318m |
Mar 31 2021 | n/a | n/a | -US$311m |
Dec 31 2020 | US$5m | US$655k | -US$307m |
Sep 30 2020 | n/a | n/a | -US$304m |
Jun 30 2020 | n/a | n/a | -US$301m |
Mar 31 2020 | n/a | n/a | -US$298m |
Dec 31 2019 | US$7m | US$319k | -US$291m |
Compensation vs Market: Pascal's total compensation ($USD5.16M) is above average for companies of similar size in the US market ($USD667.11K).
Compensation vs Earnings: Pascal's compensation has increased whilst the company is unprofitable.
CEO
Pascal Touchon (60 yo)
4.8yrs
Tenure
US$5,158,128
Compensation
Dr. Pascal Touchon, D.V.M., serves as Independent Director at Ipsen S.A. since October 4, 2023. He has been President, Chief Executive Officer and Director at Atara Biotherapeutics, Inc. since June 24, 201...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 4.8yrs | US$5.16m | 0.25% $ 210.5k | |
Executive VP & Chief Legal Officer | 4yrs | US$1.79m | 0.091% $ 78.0k | |
Executive VP & Chief Financial Officer | less than a year | no data | 0.065% $ 55.4k | |
Executive VP and Chief Scientific & Technical Officer | 2.9yrs | no data | 0.069% $ 59.1k | |
Vice President of Corporate Communications & Investor Relations | no data | no data | no data | |
Executive VP and Global Head of Regulatory Affairs & Quality | 4.3yrs | no data | 0.043% $ 36.8k | |
Executive VP & Chief Business Officer | 3.3yrs | no data | no data | |
Senior VP & Chief Medical Officer | less than a year | no data | no data |
3.3yrs
Average Tenure
50yo
Average Age
Experienced Management: ATRA's management team is considered experienced (3.3 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 4.8yrs | US$5.16m | 0.25% $ 210.5k | |
Independent Director | 9.1yrs | US$370.35k | 0.42% $ 361.9k | |
Independent Director | 8.4yrs | US$355.35k | 0.13% $ 108.6k | |
Independent Director | 10.1yrs | US$370.35k | 0.044% $ 37.2k | |
Chairman & Lead Independent Director | 11.3yrs | US$357.85k | 0.35% $ 302.0k | |
Independent Director | 2.7yrs | US$345.35k | 0.017% $ 14.7k | |
Independent Director | 3.9yrs | US$345.35k | 0.026% $ 22.5k |
8.4yrs
Average Tenure
58yo
Average Age
Experienced Board: ATRA's board of directors are considered experienced (8.4 years average tenure).